// App-Quantinova.ai

: Resected pancreatic ductal adenocarcinoma: understanding tumour tropism to maximise benefit from surgery

Researchers

Presenter

  • M. Frizziero

Principal Investigators

  • A. Malik

  • M.G. McNamara

  • S. Jamdar

  • R. Pihlak

  • A. Siriwardena

  • D. O'Reilly

  • N. De' Liguori Carino

  • A. Lamarca

Medical Centers

  • Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom

  • Hepatobiliary and Pancreatic Surgical Team, Department of Surgery, Manchester Royal Infirmary, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved